Albemarle Corporation
NYSE:ALBChemicals - Specialty
-$6.21 today
- Market cap
- $10.13B
- Beta
- 1.31
- P/E (TTM)
- -81.1
- EPS (TTM)
- -$1.98
- Dividend yield
- 1.01%
Volume 2.16M
Average 2.29M
ALB Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Albemarle CorporationNYSE: ALB
Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026
Depreciation & amortization declines year over year
Q2 FY2026 depreciation & amortization of $155.8M fell 7.7% year over year, behind the -2.3% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 1.3% from the prior quarter. Over 3 fiscal years it compounded at +29.9% a year.
Context
- Depreciation & amortization amounted to 12.8% of revenue in FY2025, up 1.9 pp from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -7.7% toward the trailing-twelve-month pace of -2.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 658.68M USD
- Year-over-year change
- +11.9%
- 4-year CAGR
- +26.9%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 658.68M | +11.9% |
| FY2024 | 2024-12-31 | 588.64M | +36.9% |
| FY2023 | 2023-12-31 | 429.94M | +42.9% |
| FY2022 | 2022-12-31 | 300.84M | +18.4% |
| FY2021 | 2021-12-31 | 254M | — |
Depreciation & Amortization vs competitors
How ALB compares with its peers on the latest reported figures
- ALB's LTM Jun 2026 depreciation & amortization of $641.8M is the highest of the 4 companies compared; the peer median is $1.11M.
- Its year-over-year change of -2.3% is the 2nd highest of 3, against a peer median of -3.0%.
- Depreciation & amortization amounts to 10.9% of revenue for ALB, versus a peer median of 6.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $641.8M | -2.3% | +29.9% | 10.9% | |
| LTM Jun 2026 | $439.37M | +12.6% | +435.4% | 6.5% | |
| LTM Mar 2026 | $1.11M | -18.5% | +9.3% | — | |
| LTM Mar 2026 | $716K | — | — | — | |
| Peer median (excluding ALB) | $1.11M | -3.0% | +222.3% | 6.5% | |
Competitors are the stored peer set for ALB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.33B | 7.32B | 9.62B | 5.38B | 5.14B |
| Cost of Revenue | 2.32B | 4.23B | 8.42B | 5.32B | 4.47B |
| Gross Profit | 1.01B | 3.09B | 1.2B | 60.24M | 671.62M |
| Gross Margin | 30.3% | 42.2% | 12.5% | 1.1% | 13.1% |
| Research & Development | 54.03M | 71.98M | 85.73M | 86.72M | 51.4M |
| Selling, General & Admin | 421.79M | 512.15M | 874.16M | 609.53M | 526.43M |
| Operating Expenses | 475.81M | 584.13M | 959.89M | 696.25M | 577.83M |
| Depreciation & Amortization | 254M | 300.84M | 429.94M | 588.64M | 658.68M |
| EBITDA | 544.86M | 3.63B | 2.65B | (294.14M) | 558M |
| EBITDA Margin | 16.4% | 49.6% | 27.5% | -5.5% | 10.9% |
| Operating Income | 532.66M | 2.5B | 241.12M | (636.01M) | 93.79M |
| Operating Margin | 16.0% | 34.2% | 2.5% | -11.8% | 1.8% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 61.48M | 122.97M | 116.07M | 165.62M | 207.65M |
| Other Income / Expenses | (303.27M) | 704.26M | 1.86B | (412.39M) | (402.12M) |
| Income Before Tax | 229.39M | 3.21B | 2.1B | (1.05B) | (308.33M) |
| Pre-Tax Margin | 6.9% | 43.8% | 21.8% | -19.5% | -6.0% |
| Income Tax Expense | 29.45M | 390.59M | 430.28M | 87.09M | 156.88M |
| Net Income | 123.67M | 2.69B | 1.57B | (1.18B) | (510.63M) |
| Net Margin | 3.7% | 36.7% | 16.4% | -21.9% | -9.9% |
| EPS (Basic) | 1.07 | 22.97 | 13.41 | (11.20) | (5.75) |
| EPS (Diluted) | 1.06 | 22.84 | 13.36 | (11.20) | (5.75) |
| Weighted Avg Shares | 115.84M | 117.12M | 117.32M | 117.52M | 117.7M |
| Weighted Avg Shares (Diluted) | 116.54M | 117.79M | 117.77M | 117.52M | 117.7M |
Albemarle Corporation
NYSE:ALB
Intrinsic Alpha fair value
Locked
Current Price
$85.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.